Company / CapEx per Share
Organon & Co. CapEx per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.63
FY2025
5-year range
$0.36 / $0.99
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#20 of 192
Health Care
What the data says
Among 192 Health Care companies, Organon & Co. is in the top 10% for capex per share. CapEx per Share has fluctuated over the past 7 years, ranging from $0.36 in FY2021 to $1.01 in FY2020.
Based on SEC 10-K filings.
0.63 in FY2025 with a 5-year CAGR of -9.0%. Top quartile in the Health Care sector.
Declined from $0.99 to $0.63 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -6.7%
- 5-Year CAGR
- -9.0%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 192This company $0.63 Sector average $2.46
▼
-74.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 8.2% year-over-year.
- Ranks #20 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 55.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.63 | -8.2% |
| FY2024 | $0.68 | -30.6% |
| FY2023 | $0.99 | +27.6% |
| FY2022 | $0.77 | +113.0% |
| FY2021 | $0.36 | -63.9% |
| FY2020 | $1.01 | +177.2% |
| FY2019 | $0.36 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026